Global Optic Neuritis Market – Industry Trends and Forecast to 2030

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Global Optic Neuritis Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • Количество таблиц: 220
  • Количество рисунков: 60

Global Optic Neuritis Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Chart Image USD 204.90 Million USD 302.70 Million 2022 2030
Diagram Прогнозируемый период
2023 –2030
Diagram Размер рынка (базовый год)
USD 204.90 Million
Diagram Размер рынка (прогнозируемый год)
USD 302.70 Million
Diagram CAGR
%
Diagram Основные игроки рынка
  • Aerie Pharmaceuticals
  • Abbvie
  • Bausch Health Companies
  • Merck & Co
  • Pfizer

>Global Optic Neuritis Market, By  Type (Oral Corticosteriods, Intravenous Corticosteriods), Applications (Paediatric Use, Geriatric Use), End-User (Hospitals, Research Institutes, Specialty Clinics),  Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030.

Optic Neuritis Market

Optic Neuritis Market Analysis and Size

About 40% to 50% patients with multiple sclerosis (MS) develop optic neuritis and about 30% of optic neuritis sufferers show signs of multiple sclerosis. A latest research showed by NCBI in 2021, found that the risk of optic neuritis is higher in people between the ages of 20 to 40. The intravenous route is projected to create a global demand for optic neuritis treatment.

Data Bridge Market Research analyses a growth rate in the optic neuritis market in the forecast period 2023-2030. The expected CAGR of optic neuritis market tend to be around 5% in the mentioned forecast period. The market was valued at USD 204.9 million in 2022, and it would grow upto USD 302.7 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Optic Neuritis Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Oral Corticosteriods, Intravenous Corticosteriods), Applications (Paediatric Use, Geriatric Use),End-User (Hospitals, Research Institutes, Specialty Clinics),  Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Aerie Pharmaceuticals, Inc. (U.S.), Abbvie, Inc (U.S.), Bausch Health Companies Inc. (Canada.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), EyePoint Pharmaceuticals, Inc (U.S.) Amorphex Therapeutics Holdings, Inc (U.S.), Kubota Vision Inc (U.S.), Alcon Vision LLC (Switzerland), Ellex Medical (Australia), Lumenis Be Ltd (Israel), Acorn Biomedical, Inc (U.S.), Astellas Pharma Inc (Japan), Glenmark Pharmaceuticals Ltd (India), Bayer AG (Germany), and Novartis AG (Switzerland)

Market Opportunities

  • Increase in Smoking and Lifestyle Changes
  • Increasing Incidence of Optic neuritis

Market Definition

Optic neuritis is a kind of nerve damage that occurs because of high level of blood sugar in the body. The symptoms can initiate from pain, numbness in legs and feet, to urinary tract, blood vessels and heart. It is a type of diabetes complication which may affect people with diabetes. Optic neuritis is a serious and common complication of long term type 1 and type 2 diabetes.

Optic Neuritis Market Dynamics

Drivers

  • Rising Demand of Therapy Segment

There are different types of therapy that increases the demand of the market. Steroidal therapy includes corticosteroid drugs, which have proven efficient for many years. This segment is anticipated to show major market share, due to its proven efficacy and increasing availability across the globe. Supplementary therapy, on the other hand, includes vitamin supplementation therapy with vitamin B12. Immunomodulators therapy involves disease modifying agents, such as interferons beta1a and beta1b that are found to be beneficial in the treatment of optic neuritis and multiple sclerosis.

Opportunities

  • Growth in Smoking and Lifestyle Changes

Cigarette smoking is one of the top causes of preventable disease and death in the U.S. It  results for more than 480,000 deaths each year. Additionally, the lifestyle changes that are attained by today’s population such as unhealthy lifestyle, poor diet, stress and many such factors altogether contribute to the developing opportunities of the market.

  • Increasing Incidence of Optic neuritis

Optic neuritis disease can occur at any age, but many of the cases occur in women who are between the age group of 20 to 40 years. In addition to this, as per the Optic Neuritis Foundation Inc, an estimation of 15-20% of the people suffering from optic neuritis are expected to end up suffering from multiple sclerosis.

Restraints/Challenges

  • Increase in stringent regulatory policies

The strict regulatory policies is set to impede the global optic neuritis market growth during the forecast period. The strict regulations, delays in Food and Drug Administration certifications, product recalls, and other similar issues may further impede the growth of this industry.

  • High Cost of Treatment

The enormous expenditure which is required for the treatment processes hamper the market growth. Several market players make huge investment in manufacturing new and advanced treatment procedures to faster the recovery process and in return the cost is increased. For instance, developing new drug treatments for a disease costs $314 million to $2.8 billion, will impede the market during the forecast period.

This optic neuritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the optic neuritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Optic Neuritis Market Scope

The optic neuritis market is segmented on the basis of type, application, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Oral Corticosteriods
  • Intravenous Corticosteriods

Applications

  • Paediatric Use
  • Geriatric Use

End-User

  • Hospitals
  • Research Institutes
  • Specialty Clinics

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

Global Optic Neuritis Market Regional Analysis/Insights

The optic neuritis market is analyzed and market size insights and trends are provided by type, application, distribution channel and end-user as referenced above.

The major countries covered in the optic neuritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

Asia-Pacific is expected to account for the largest market share in the coming years for the optic neuritis market due to increased new research and developments on optic neuritis market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Optic Neuritis Market Share Analysis

The optic neuritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to optic neuritis market

Key players operating in the optic neuritis market include:

  • Aerie Pharmaceuticals, Inc. (U.S.)
  • Abbvie, Inc (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Merck & Co. Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • EyePoint Pharmaceuticals, Inc (U.S.)
  • Amorphex Therapeutics Holdings, Inc (U.S.)
  • Kubota Vision Inc (U.S.)
  • Alcon Vision LLC (Switzerland)
  • Ellex Medical (Australia)
  • Lumenis Be Ltd (Israel)
  • Acorn Biomedical, Inc (U.S.)
  • Astellas Pharma Inc (Japan)
  • Glenmark Pharmaceuticals Ltd (India)
  • Bayer AG (Germany)
  • Novartis AG (Switzerland)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

Рынок сегментирован на основе , By  Type (Oral Corticosteriods, Intravenous Corticosteriods), Applications (Paediatric Use, Geriatric Use), End-User (Hospitals, Research Institutes, Specialty Clinics),  Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030. .
Размер Global Optic Neuritis Market в 2022 году оценивался в 204.90 USD Million долларов США.
Ожидается, что Global Optic Neuritis Market будет расти со среднегодовым темпом роста (CAGR) 5% в течение прогнозируемого периода 2023–2030.
Основные участники рынка включают Aerie Pharmaceuticals, Abbvie, Bausch Health Companies, Merck & Co, Pfizer, Teva Pharmaceutical Industries, EyePoint Pharmaceuticals, Amorphex Therapeutics Holdings, Kubota Vision, Alcon Vision, Ellex Medical, Lumenis Be, Acorn Biomedical, Astellas Pharma, Glenmark Pharmaceuticals, Bayer, Novartis.
Отчет по рынку охватывает данные из U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Testimonial